TETmedical, Inc.
PrivateLast Round
Seed Round
Jun 12, 2026
Total Funding Raised
$3.79M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
TETmedical, Inc. operates in Healthcare & Life Sciences and is based in Ithaca, New York. Its latest recorded funding round was a Grant round in December 2023.
TETmedical, Inc. is a diagnostic equipment company that develops an in-vitro diagnostic nanomedicine platform designed for clinical diagnostic use.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TETmedical, Inc. Comparables
Compare TETmedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Upfront Diagnostics | 81% | |
| Galaxy CCRO, Inc. | 79% | |
| NanoDx | 76% |
For institutional investors. Book with your work email.
TETmedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 12, 2026 | ||||
| Grant | Dec 15, 2023 | ||||
| Seed | May 31, 2023 | ||||
| Grant | May 4, 2023 |
For institutional investors. Book with your work email.
TETmedical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launchpad Venture Group | Seed Round, Seed |
| NIH RADx | Grant |
| Frontier Angels | Seed Round, Seed |
| Bantam Group | Seed Round, Seed |
| Beacon Venture Partners | Seed |
| eCoast Angels | Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 6, representing 40% of headcount.
- Jun 12, 2026
Raised $4M in a seed funding round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 10, 2026
On Nov 10th '26, in New Jersey and New York, TETmedical, Inc. announces that Evan Gerber, M.D., is set to serve as a Medical Advisor and advise on clinical strategy, study design, and integrating NSE-FAST into emergency department workflows.
- hiresNov 10, 2026
TETmedical, Inc. announces that Hooman Kamel, M.D., M.S., will serve as a Medical Advisor and advise on clinical strategy, study design, and NSE-FAST integration into emergency department workflows in New Jersey and New York on Nov 10th '26.
- hiresSep 29, 2026
TETmedical, Inc. appoints Patrick McBrayer to its Board of Directors after he serves as president and CEO of Miach.
- is_developingSep 29, 2026
TETmedical, Inc. is developing NSE-FAST to aid in diagnosing acute ischemic stroke by measuring Neuron Specific Enolase activity in plasma, with the product remaining in clinical development ahead of a planned multicenter pivotal study expected to begin in Q4 '26.
- hiresSep 29, 2026
TETmedical, Inc. appoints Arjun Ishwar as Chief Commercial Officer on Sep 29th '26 in New Jersey and New York, as he joins its executive leadership team while it advances NSE-FAST(R) toward a multi-center pivotal study and builds commercial infrastructure for launch in the United States and internationally.
For institutional investors. Book with your work email.
TETmedical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TETmedical, Inc.'s valuation, stock price, and market status.
Is TETmedical, Inc. a public or private company?
TETmedical, Inc. is a private company.
What is the current stock price of TETmedical, Inc.?
TETmedical, Inc. is a private company, so its shares have no public market price. Caplight tracks TETmedical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TETmedical, Inc. worth (valuation)?
Valuation information for TETmedical, Inc. is not publicly available.
Can I buy TETmedical, Inc. stock?
TETmedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TETmedical, Inc.'s last funding round?
TETmedical, Inc.'s most recent funding round was Seed Round on June 12, 2026.
Who are the main investors in TETmedical, Inc.?
Key investors in TETmedical, Inc. include Launchpad Venture Group, NIH RADx, Frontier Angels, Bantam Group, Beacon Venture Partners.
Will TETmedical, Inc. IPO soon?
No public IPO plans have been announced for TETmedical, Inc..
How can I track TETmedical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in TETmedical, Inc.'s shares on secondary markets.